ImmunoScape vs Kite Pharma
ImmunoScape vs Kite Pharma, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ImmunoScape is on 58/100 and Kite Pharma on 66/100.
Where each one leads
ImmunoScape
- agent readiness: 39/100 against 35/100
Kite Pharma
- our overall score: 66/100 against 58/100
- domain rating: 62/100 against 28/100
- funding raised: $421M against $49.7M
At a glance
| Measure | ImmunoScape | Kite Pharma |
|---|---|---|
| What it is | Developing novel immunotherapies and diagnostics for cancer. | Biotechnology company developing and commercializing cell therapies for cancer treatment. |
| Category | Biotechnology, Cancer, Immunotherapy, Diagnostics | Biotechnology, Pharmaceuticals, Oncology, Cell Therapy |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2017 | 2009 |
| Headquarters | Singapore, Singapore | Santa Monica, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | ImmunoScape | Kite Pharma |
|---|---|---|
| Total funding | $49.7M | $421M |
| Latest round | Series B2 | Venture |
| Valuation | $1.1B | Not published |
| LinkedIn followers | 4,364 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | ImmunoScape | Kite Pharma |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 58/100 | 66/100 |
| Traction | 38/100 | 40/100 |
| Team | 70/100 | 80/100 |
| Search visibility | 23/100 | 15/100 |
| Quality | 68/100 | 90/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (35/100) |
| Domain ratingLink authority, 0-100 | 28/100 | 62/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | ImmunoScape | Kite Pharma |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Tailwind CSS, Bootstrap |
| Analytics | Google Tag Manager | Google Tag Manager |
What users say
| Measure | ImmunoScape | Kite Pharma |
|---|---|---|
| Reddit sentimentThreads we track | 6 positive, 0 negative across 6 threads | Not published |
“Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments.”r/Quantisnow
ImmunoScape vs Kite Pharma: common questions
Which is better, ImmunoScape or Kite Pharma?
On our 0-100 score Kite Pharma rates higher (66/100 against 58/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do ImmunoScape and Kite Pharma compare on the numbers?
ImmunoScape leads on agent readiness (39/100 against 35/100). Kite Pharma leads on our overall score (66/100 against 58/100), domain rating (62/100 against 28/100), funding raised ($421M against $49.7M).
What do real users say about ImmunoScape and Kite Pharma?
ImmunoScape: 6 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/Quantisnow.
Read the full ImmunoScape review and pricing or the Kite Pharma review and pricing. You can also browse other ImmunoScape alternatives we track.